Eli Lilly is conducting an Open-Label Study of XXXXXXXXXX in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab.

To participate in your local study, please contact  (949) 844-0442 or fill out the form below.

Protocol # J2T-MC-KGBO

Share this post

Subscribe To Our Newsletter

Get updates and learn from the best

More To Explore

Call us, write us, or knock on our door.